UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer

Clinical cancer research, 2016-01, Vol.22 (1), p.230-242

2016

Volltextzugriff (PDF)

AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer

Clinical cancer research, 2014-01, Vol.20 (1), p.164-175

2014

Volltextzugriff (PDF)

Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5717

2023

Volltextzugriff (PDF)

Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application

Briefings in bioinformatics, 2019-09, Vol.20 (5), p.1795-1811

2019

Volltextzugriff (PDF)

Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches

Cancers, 2022-07, Vol.14 (15), p.3726

2022

Volltextzugriff (PDF)

Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data

PloS one, 2013-06, Vol.8 (6), p.e66902-e66902

2013

Volltextzugriff (PDF)

PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer

The Journal of pathology, 2011-08, Vol.224 (4), p.564-574

2011

Volltextzugriff (PDF)

Compositional analysis gives insight into leukaemia cell lines expression profiles compared to those within patient sub‐groups

British journal of haematology, 2018-06, Vol.181 (6), p.847-851

2018

Volltextzugriff (PDF)

A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia

Scientific reports, 2020-10, Vol.10 (1), p.18514-18514, Article 18514

2020

Volltextzugriff (PDF)

Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line

Nucleic acids research, 2016-09, Vol.44 (17), p.e137

2016

Volltextzugriff (PDF)

Modular Chemical Construction of IgG-like Mono- and Bispecific Synthetic Antibodies (SynAbs)

ACS central science, 2023-03, Vol.9 (3), p.476-487

2023

Volltextzugriff (PDF)

Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology

European urology, 2017-10, Vol.72 (4), p.509-518

2017

Volltextzugriff (PDF)

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer

Journal of oncology, 2018-01, Vol.2018, p.2937012-14

2018

Volltextzugriff (PDF)

B-vitamin status in relation to bone mineral density in treated celiac disease patients

Scandinavian journal of gastroenterology, 2015-08, Vol.50 (8), p.975-984

2015

Volltextzugriff (PDF)

Profiling of the BRCA1 transcriptome through microarray and ChIP-chip analysis

Nucleic acids research, 2011-12, Vol.39 (22), p.9536

2011

Volltextzugriff (PDF)

BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers

Nucleic acids research, 2013-10, Vol.41 (18), p.8601

2013

Volltextzugriff (PDF)

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma

Oncotarget, 2018-04, Vol.9 (26), p.18518-18528

2018

Volltextzugriff (PDF)

Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma

European journal of cancer (1990), 2012-11, Vol.48 (16), p.2983-2992

2012

Volltextzugriff (PDF)

Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis

Nature communications, 2015-10, Vol.6 (1), p.8802-8802, Article 8802

2015

Volltextzugriff (PDF)

PICan: An integromics framework for dynamic cancer biomarker discovery

Molecular oncology, 2015-06, Vol.9 (6), p.1234-1240

2015

Volltextzugriff (PDF)

Combination Therapies Targeting Apoptosis in Paediatric AML: IUnderstanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics/I

International journal of molecular sciences, 2023-03, Vol.24 (6)

2023

Volltextzugriff (PDF)

Defining an IBD-like subgroup in consensus molecular subgroups of colorectal cancer and transcriptomic biomarker development for at-risk patients

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15142-e15142

2019

Volltextzugriff (PDF)

Abstract 2999: Identification of Src's role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.2999-2999

2020

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(40)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer

AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer

Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics

Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application

Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches

Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data

PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer

STAT3 regulated ARF expression suppresses prostate cancer metastasis

Compositional analysis gives insight into leukaemia cell lines expression profiles compared to those within patient sub‐groups

A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line

Modular Chemical Construction of IgG-like Mono- and Bispecific Synthetic Antibodies (SynAbs)

Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer

B-vitamin status in relation to bone mineral density in treated celiac disease patients

Profiling of the BRCA1 transcriptome through microarray and ChIP-chip analysis

BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma

Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma

Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis

PICan: An integromics framework for dynamic cancer biomarker discovery

Combination Therapies Targeting Apoptosis in Paediatric AML: IUnderstanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics/I

Defining an IBD-like subgroup in consensus molecular subgroups of colorectal cancer and transcriptomic biomarker development for at-risk patients

Abstract 2999: Identification of Src's role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches

Suchergebnisse filtern